HCRT and epilepsy: The chemical chaperone (and putative HSP70 modulator) 4-PBA, restored the activity of folding-deficient hCRT-1 mutants linked to severe intellectual disability and epilepsy in our recent studies (El-Kasaby et al., 2019; Farr et al., 2020).